Skip to main content
SpringerLink
Log in
Book cover

Nuclear Cardiology and Cardiac Magnetic Resonance pp 25–44Cite as

Metabolism: Assessment of myocardial metabolism with radiolabeled free fatty acids

  • Chapter

  • 56 Accesses

Abstract

The regional, noninvasive assessment of myocardial functional integrity with the aim of identifying normal, ischemic and necrotic zones is highly desirable in patients with coronary artery disease (CAD). Therefore attempts have been made to determinate the metabolic integrity of the myocardium quantitatively with radioactively labeled metabolic substrates. Since free fatty acids (FFA) are primary substrates of the normally perfused myocardium, it appears likely that radiolabeled FFA are suitable for the study of myocardial FFA metabolism.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Machulla HJ, Stöcklin G, Kupfemagel C, et al. (1978) Comparative evaluation of fatty acids labeled with C-11, C1-34m, Br-77 and I-123 for metabolic studies of the myocardium: concise communication. J Nucl Med 19: 298–302.

    PubMed  CAS  Google Scholar 

  2. Poe ND, Robinson jr GD, Graham LS, MacDonald NS (1976) Experimental basis for myocardial imaging with 1-123-labeled hexadecenoic acid. J Nuel Med 17: 1077-82.

    Google Scholar 

  3. Schelbert HR, Henze E, Huang SC, Phelps ME (1981) Relationship between myocardial blood flow and uptake and utilization of free fatty acids (FFA) J Nucl Med (abstract) 22: P10.

    Google Scholar 

  4. Henze E, Guzy P, Schelbert HR (1983) Metabolic effects of cardiac work on normal and ischemic myocardum in man measured noninvasively with C-11-palmitate and positron emission tomography (PET). Eur Soc Cardiol Working Group on Use of Isotopes in Cardiol, Rotterdam (abstract).

    Google Scholar 

  5. Dudczak R, Kletter K, Frischauf H, Losert U, Angelberger P, Schmoliner R (1984) The use of I-123-labeled heptadecanoic acid (HDA) as metabolic tracer: Preliminary report. Eur J Nucl Med 9: 81–5.

    Article  PubMed  CAS  Google Scholar 

  6. Comet M, Wolf JE, Pilichowski P, et al. (1982) Influence du propranolol sur I’active myocardique apres injection i.v. d’acide 16 I(123) hexadecene-9-oique. In: Faivre G, Bertrand A, Cherrier F, Amor M, Neimann JL (eds) Noninvasive methods in ischemic heart disease. Nancy, Specia, pp 295–

    Google Scholar 

  7. Styles CB, Noujaim A A, Jugdutt BI, et al. (1983) Effect of doxorubicin on (omega-I-131) heptadecanoic acid myocardial scintigraphy and echocardiography in dogs. J Nucl Med 24: 1012–8.

    PubMed  CAS  Google Scholar 

  8. Stiicklin G (1981) Evaluation of radiohalogen labelled fatty acids for heart studies. Nuklearmedizin (Suppl) 19: 1–6.

    Google Scholar 

  9. Lerch RA, Ambos RD, Bergmann SR, Welch MJ, Ter-Pogossian MM, Sobel BE (1981) Localization of viable, ischemic myocardium by positron-emission tomography with C-11-palmitate. Circulation 64: 689–99.

    Google Scholar 

  10. Lerch RA, Bergmann SR, Ambos HD, Welch MJ, Ter-Pogossian MM, Sobel BE (1982) Effect of flowindependent reduction of metabolism on regional myocardial of C-ll-palmitate. Circulation 65: 731–8.

    Google Scholar 

  11. Schelbert HR, Phelps ME, Hoffman E, Huang SC, Kuhl DE (1980) Regional myocardial blood flow, metabolism and function assessed noninvasively with positron emission tomography. Am J Cardiol 46: 1269–77.

    Google Scholar 

  12. Schön HR, Schelbert HR, Najafi A, et al. (1982) C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C-11-palmitic acid in acutely ischemic myocardium. Am Heart J 103: 548–61.

    Article  PubMed  Google Scholar 

  13. Visser FC, Westera G, Eenige van MJ, van der Wall EE, den Hollander W, Roos JP (1985) The myocardial elimination rate of radioiodinated heptadecanoic acid. Eur J Nucl Med 10: 118–22.

    Article  PubMed  CAS  Google Scholar 

  14. Kloster G, Stiicklin G, Smith EF, Schriir K (1984) Omega-halofatty acids: A probe for mitochondrial membrane integrity. In vitro investigations in normal and ischaemic myocardium. Eur J Nucl Med 9: 305–11.

    Article  PubMed  CAS  Google Scholar 

  15. Weiss ES, Hoffman EJ, Phelps ME, et al. (1976) External detection and visualization of myocardial ischemia with C-11-substrates in vitro and in vivo. Circ Res 39: 24–32.

    PubMed  CAS  Google Scholar 

  16. Weiss ES, Ahmed SA, Welch MJ, Williamson JR, Ter-Pogossian MM, Sobel BE (1977) Quantification of infarction in cross sections of canine myocardium in vivo with positron emission transaxial tomography and C-11-palmitate. Circulation 55: 66–73.

    Google Scholar 

  17. Sobel BE, Weiss ES, Welch MJ, Siegel BA, Ter-Pogossian MM (1977) Detection of remote myocardial infarction in patients with positron emission transaxial tomography and intravenous C-11-palmitate. Circulation 55: 853–57.

    PubMed  CAS  Google Scholar 

  18. Ter-Pogossian MM, Klein MS, Markham J, Roberts R, Sobel BE (1980) Regional assessment of myocardial metabolic integrity in vivo by positron-emission tomography with C-ll-labeled palmitate. Circulation 61: 242–55.

    Google Scholar 

  19. Geltman EM, Biello D, Welch MJ, Ter-Pogossian MM, Roberts R, Sobel BE (1982) Characterization of nontransmural myocardial infarction by positron-emission tomography. Circulation 65: 747–55.

    Article  PubMed  CAS  Google Scholar 

  20. Schon HR, Schelbert HR, Robinson G, Najafi A, Huang SC, Hansen H (1982). C-11-labeled palmitate acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C-11-palmitic acid in normal myocardium. Am Heart J 103: 532–47.

    Article  PubMed  CAS  Google Scholar 

  21. Bergmann SR, Lerch RA, Fox KAA, et al. (1982) Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med 73: 573–81.

    Article  PubMed  CAS  Google Scholar 

  22. Ludbrook PA, Geltman EM, Tiefenbrunn AJ, Jaffe AS, Sobel BE (1983) Restoration of regional myocardial metabolism by coronary thrombolysis in patients. Circulation (abstract) (Suppl. III):325.

    Google Scholar 

  23. Goldstein RA, Klein MS, Welch MJ, Sobel BE (1980) External assessment of myocardial metabolism with C-11-palmitate in vivo. J Nucl Med 21: 342–8.

    PubMed  CAS  Google Scholar 

  24. Evans JR, Phil D, Gunton RW, Baker RG, Spears JC, Beanlands DS (1965) Use of radioiodinated fatty acid for photoscans of the heart. Cire Res 16: 1–10.

    CAS  Google Scholar 

  25. Robinson jr GD, Lee A W (1975) Radioiodinated fatty acids for heart imaging: iodine monochloride addition compared with iodide replacement labeling. J Nucl Med 16: 17–21.

    PubMed  CAS  Google Scholar 

  26. Poe ND, Robinson jr GD, MacDonald NS (1975) Myocardial extraction of labeled long-chain fatty acid analogs. Proc Soc Exp Bioi Med 148: 215–8.

    CAS  Google Scholar 

  27. Otto CA, Brown LE, Wieland DM, Beierwaltes WH (1981) Radioiodinated fatty acid for myocardial imaging: Effects of chain length. J Nucl Med 22: 613–8.

    Google Scholar 

  28. Westera G, van der Wall EE, Heidendal GAK, van den Bos GC (1980) A comparison between terminally radioiodinated hexadecenoic acid (I-HA) and T1-201-thallium chloride in the dog heart. Implications for the use of I-HA for myocardial imaging. Eur J Nucl Med 5: 339–43.

    Article  PubMed  CAS  Google Scholar 

  29. Poe ND, Robinson jr GD, Zielinski FW, Cabeen jr WR, Smith JW, Gomes AS (1977) Myocardial imaging with I-123-hexadecenoic acid. Radiology 124: 419–24.

    PubMed  CAS  Google Scholar 

  30. Freundlieb C, Höck A, Vyska K, Feinendegen LE, Machulla HJ, Stöcklin G (1980) Myocardial imaging and metabolic studies with (17-I-123)iodoheptadecanoic acid. J Nucl Med 21: 1043–50.

    PubMed  CAS  Google Scholar 

  31. Van der Wall EE, Heidendal GAK, den Hollander W, Westera G, Roos JP (1980) I-123 labeled hexadecenoic acid in comparison with thallium-201 for myocardial imaging in coronary heart disease. A preliminary study. Eur J Nucl Med 5: 401–5.

    Article  PubMed  Google Scholar 

  32. Rösier H, Hess T, Weiss M. et al. (1983) Tomoscintigraphic assessment of myocardial metabolic heterogeneity. J Nucl Med 24: 285–96.

    Google Scholar 

  33. Van der Wall EE, den Hollander W, Heidendal GAK, Westera G, Majid PA, Roos IP (1981) Dynamic myocardial scintigraphy with I-123 labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med 6: 383–9.

    PubMed  Google Scholar 

  34. Aurich D, Reske SN, Biersack HJ, et al. (1982) Biplanar sequential scintigraphy of the myocardium by means of 123-I-heptadecanoic acid. In: Raynaud C (ed) Nucl Med Biol, Proc third World Congr Nucl Med Biol Paris II Pergamon Press, pp 1389–91.

    Google Scholar 

  35. Van der Wall EE, Heidendal GAK, den Hollander W, Westera G, Roos IP (1981) Metabolic myocardial imaging with I-123 labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med 6: 391–6.

    PubMed  Google Scholar 

  36. Van der Wall EE, Westera G, den Hollander W, Roos JP, Visser FC (1981) External detection of regional myocardial metabolism with radioiodinated hexadecenoic acid in the dog heart. Eur J Nucl Med 6: 147–51.

    Article  PubMed  Google Scholar 

  37. Huckell VF, Lyster DM, Morrison RT (1980) The potential role of 123 iodine-hexadecenioc acid in assessing normal and abnormal myocardial metabolism. J Nucl Med (abstract) 21: P57.

    Google Scholar 

  38. Pachinger O, Sochor H, Ogris E, Probst P, Klicpera M, Kaindl F (1982) Salvage of ischemic myocardium by intracoronary streptokinase therapy? In: Faivre G, Bertrand A, Cherrier F, Amor M, Neimann IL (eds) Noninvasive methods in ischemic heart disease. Nancy, Specia, pp 410–

    Google Scholar 

  39. Visser F C, Westera G, van der Wall EE, Roos IP (1985) Dynamic free fatty acid scintigraphy in patients with successful thrombolysis after acute myocardial infarction. Clin Nucl Med 10: 35–9.

    Article  PubMed  CAS  Google Scholar 

  40. Hock A, Freundlieb C, Vyska K, Losse B, Erbel R, Feinendegen LE (1983) Myocardial imaging and metabolic studies with (17-I-123)iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy. J Nucl Med 24: 22–8.

    Google Scholar 

  41. Rabinovitch MA, Kalff V, Allen R, et al. (1985) 123-I-Hexadecanoic acid metabolic probe of cardiomyopathy. Eur J Nucl Med 10: 222–7.

    Article  PubMed  CAS  Google Scholar 

  42. Freundlieb C, Hock A, Vyska K, Erbel R, Feinendegen LE (1982) Fatty acid uptake and turnover rate in the ischemic heart before and after bypass surgery. In: Raynaud (ed) Nucl Med Biol, Proc third World Congr Nucl Med Biol Paris II Pergamon Press pp 1392–5.

    Google Scholar 

  43. Höck A, Freundlieb C, Vyska K, et al. (1982) The influence of rehabilitation training on fatty acid metabolism in patients with myocardial infarction. In: Faivre G, Bertrand A, Cherrier F, Arnor M, Niemann JL (eds) Non invasive methods in ischemic heart disease. Nancy, Specia, pp 300–3.

    Google Scholar 

  44. Machulla HJ, Marsmann M, Dutschka K (1980) Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium. Eur J Nucl Med 5: 171–3.

    Article  PubMed  CAS  Google Scholar 

  45. Reske SN, Schon S, Knust EJ, et al. (1984) Relation of myocardial blood flow and initial cardiac uptake of 15-(p-I-123-phenyl)-pentadecanoic acid in the canine heart. Nucl Med 23: 83–5.

    CAS  Google Scholar 

  46. Sun QX, Zhang J, Ji QM, et al. (1984) Pharmacology of radioiodinated hexadecenoic acid. A myocardial imaging agent. Nucl Med 23: 73–4.

    CAS  Google Scholar 

  47. Coenen HH, Harmand MF, Kloster G, Stiicklin G (1981) 15-(p-(Br-75)bromophenyl)-pentadecanoic acid: Pharmacokinetics and potential as heart agent. J Nucl Med 22: 891–6.

    PubMed  CAS  Google Scholar 

  48. Dudczak R, Schmoliner R, Kletter K, Frischauf H, Angelberger P (1983) Clinical evaluation of 1-123-labeled p-phenylpentadecanoic acid (p-IPPA) for myocardial scintigraphy. J Nucl Med All Sci 27: 267–9.

    CAS  Google Scholar 

  49. Rellas IS, Corbett JR, Kulkarni P, et al. (1983) Iodine-123-phenylpentadecanoic acid: Detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. Am J Cardiol 52: 1326–32.

    Article  PubMed  CAS  Google Scholar 

  50. Reske SN, Biersack HJ, Lackner K, et al. (1982) Assessment of regional myocardial uptake and metabolism of omega-(p-I-123-phenyl)-pentadecanoic acid with serial single-photon emission tomography. Nucl Med 21: 249–53.

    CAS  Google Scholar 

  51. Visser FC, van der Wall EE, Eenige van MJ. Elimination rates of I-123-labeled phenylpentadecanoic acid in patients after acute myocardial infarction. Preliminary results.

    Google Scholar 

  52. Reske SN (1985) 123-I-Phenylpentadecanoic acid as a tracer of cardiac free fatty acid metabolism. Experimental and clinical results. Eur Heart J (suppl B) 6: 39–47.

    PubMed  CAS  Google Scholar 

  53. Reske SN, Machulla HJ, Biersack HI, Simon H, Knopp R, Winkler C (1982) Metabolic turnover of P-I-123-phenylpentadecanoic acid in the myocardium. In: Raynaud C (ed) Nucl Med Biol, Proc third World Congr Nucl Med Bioi Paris III Pergamon Press, pp 2522–5.

    Google Scholar 

  54. Okada RD, Knapp jr FF, Elmaleh DR, Yasuda T, Boucher CA, Strauss HW (1982) Tellurium-123mlabeled-9-telluraheptadecanoic acid: A possible cardiac imaging agent. Circulation 65: 305–10.

    Article  PubMed  CAS  Google Scholar 

  55. Elmaleh D, Knapp jr FF, Yasuda T, et al. (1981) Myocardial imaging with 9-(Te-123m)telluraheptadecanoic acid. J Nucl Med 22: 994–9.

    PubMed  CAS  Google Scholar 

  56. Livni E, Elmaleh DR, Levy S, Brownell GL, Strauss H W (1982) Beta-methyl( 1-C-11 )heptadecanoic acid: A new myocardial metabolic tracer for positron emission tomography. J Nucl Med 23: 169–75.

    PubMed  CAS  Google Scholar 

  57. van der Wall EE, Barrett E, Strauss HW, et al. (1985) Altered uptake and kinetics of radioiodinated 15-P( I-125)-iodophenyl-3-methylpentadecanoic acid in diabetic myocardium. Circulation (abstract) 72 (suppl III): 424.

    Google Scholar 

  58. Schwaiger M, Schelbert HR, Keen R, et al. (1985) Retention and clearance of C-11-palmitic acid in ischemic and reperfused canine myocardium. J Am Coll Cardiol 6: 311–20.

    Article  PubMed  CAS  Google Scholar 

  59. Machulla HJ, Knust EJ (1984) Recent developments in the field ofl-123-radiopharmaceuticals. Nucl Med 23:111–8.

    CAS  Google Scholar 

  60. van der Wall EE (1984) Myocardial imaging with radiolabeled free fatty acids. In: Simoons M L, Reiber J H C (eds) Nuclear imaging in clinical cardiology. The Hague: Martinus Nijhoff, pp 83–

    Chapter  Google Scholar 

  61. van der Wall EE (1985) Myocardial imaging with radiolabeled free fatty acids: A critical review. Eur Heart J (suppl B) 6: 29–38.

    Google Scholar 

  62. Schelbert HR, Henze E, Keen R, Huang H, Barrio J, Phelps M (1982) Regional fatty acid metabolism in acute myocardial ischemia demonstrated noninvasively by C-11-palmitate (CPA) and positron tomography (PET). Circulation (abstract) 66 (suppl II): 126.

    Google Scholar 

  63. Vyska K, Höck A, Freundlieb C, et al. (1979) Myocardial imaging and measurement of myocardial fatty acid metabolism using omega-I-123-heptadecanoic acid. J Nucl Med (abstract) 20: 650.

    Google Scholar 

  64. Grover M, Schelbert HR (1985) Assessment of regional myocardial substrate metabolism with positron emission tomography. In: G Pohost (Ed) New concepts in cardiac imaging 1985 Boston. Hall Medical Publishers.

    Google Scholar 

  65. Schelbert HR, Phelps ME, Shine K I (1983) Imaging metabolism and biochemistry: a new look at the heart. Am Heart J 105: 552–26.

    Google Scholar 

  66. Fox KAA, Abendschein DR, Ambos HD, Sobel BE, Bergmann SR (1985) Efflux of metabolized and nonmetabolized fatty acid from canine myocardium tomographically. Cire Res 57: 232–43.

    CAS  Google Scholar 

  67. van der Wall EE (1986) Myocardial imaging with radiolabeled free fatty acids: Applications and limitations. Eur J Nucl Med 12: S11–S15.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Ernst Evert van der Wall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1992 E.E. van der Wall

About this chapter

Cite this chapter

van der Wall, E.E. (1992). Metabolism: Assessment of myocardial metabolism with radiolabeled free fatty acids. In: Nuclear Cardiology and Cardiac Magnetic Resonance. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2826-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-2826-1_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-1780-7

  • Online ISBN: 978-94-011-2826-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation